000 | 01922 a2200541 4500 | ||
---|---|---|---|
005 | 20250513100708.0 | ||
264 | 0 | _c19961127 | |
008 | 199611s 0 0 eng d | ||
022 | _a0891-0618 | ||
024 | 7 |
_a10.1016/0891-0618(96)00134-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNishino, H | |
245 | 0 | 0 |
_a3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. _h[electronic resource] |
260 |
_bJournal of chemical neuroanatomy _cJun 1996 |
||
300 |
_a209-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aAstrocytes _xchemistry |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aDyspnea _xchemically induced |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xanalysis |
650 | 0 | 4 |
_aGuanidines _xpharmacology |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
650 | 0 | 4 |
_aNeostriatum _xdrug effects |
650 | 0 | 4 |
_aNeuritis _xchemically induced |
650 | 0 | 4 |
_aNeurotoxins _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitro Compounds |
650 | 0 | 4 |
_aPropionates _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aTacrolimus _xpharmacology |
700 | 1 | _aFujimoto, I | |
700 | 1 | _aShimano, Y | |
700 | 1 | _aHida, H | |
700 | 1 | _aKumazaki, M | |
700 | 1 | _aFukuda, A | |
773 | 0 |
_tJournal of chemical neuroanatomy _gvol. 10 _gno. 3-4 _gp. 209-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0891-0618(96)00134-2 _zAvailable from publisher's website |
999 |
_c8805971 _d8805971 |